Celebrating our 10th anniversary – Unlock our special offer today

Technology and Innovation

The UK’s new PAS: how much will compliance cost?

16th July 2015 - News analysis |

British e-cigarette companies can expect an array of new scientific and quality-control costs after the official launch today of the publicly available specification (PAS) for e-cig manufacture and testing from the British Standards Institution (BSI).

In depth: how common are e-cig fires, and why do they start?

6th May 2015 - Market reports , Topic market reports |

As the use of e-cigarettes has spread, so has the number of fires started by them. But while this has raised some concerns and generated some headlines, these incidents form a small proportion of fires overall, and the risk comes mostly from poor-quality and counterfeit batteries – hazards that could be eliminated with improved regulation and consumer education.

If it’s Saturday, this must be Shenzhen (and an e-cig expo)

19th March 2015 - News analysis |

While delegates to this week’s World Conference on Tobacco or Health in Abu Dhabi presumably must decide which of the title’s categories e-cigarettes fall into, those who’ve missed it have another choice to make: just how many of the plethora of e-cig-related events in upcoming months they should attend. The conference in the United Arab Emirates (UAE) is quickly followed » Continue Reading.

Creating a smoking alternative: the inside story of Ploom

30th September 2014 - News analysis |

          E-cigarettes and modified-risk tobacco products may change the face of smoking as we know it today. In this article, republished from Tobacco Journal International exclusively for ECigIntelligence readers, Ploom co-founder and chief technology officer Adam Bowen relates the story of “the Ploom experience”. Ploom was based first and foremost on one simple but powerful idea: » Continue Reading.

UK pharma regulator approves cigarette-like vapour device

12th September 2014 - News analysis |

Britain’s medicines regulator has issued a product licence for the nicotine inhaler Voke, which will be sold by British American Tobacco’s subsidiary Nicoventures and looks likely to be the closest pharmaceutically-approved competitor to the e-cigarette.